Categories
- Medical Conditions
- Drugs and Medications (114)
- Fitness (41)
- Health Care (206)
- Medical Conditions (935)
- Medical Procedures (148)
- Medical Tests & Examinations (220)
- Recent Articles (10)
- Children Health
- Drugs and Medications (3)
- First Aid Measures (32)
- Medical Condition (59)
- Pediatric Articles (53)
- Health Recipes
- Cooking Instructions / Cooking Demo (2)
- Low Cholesterol (106)
- Low Cholesterol Salad (2)
- Slimmers (64)
- Vegetarian (64)
- Vegetarian Salad (3)
- Food Calories (970)
ADRENOLEUKODYSTROPHY
Definition
Adrenoleukodystrophy is a rare genetic disease characterized by a
loss of myelin surrounding nerve cells in the brain and progressive adrenal
gland dysfunction.
Description
Adrenoleukodystrophy (ALD) is a member of a group of diseases,
leukodystrophies that cause damage to the myelin sheath of nerve cells.
Approximately one in 100,000 people is affected by ALD. There are three basic
forms of ALD: childhood, adult-onset, and neonatal. The childhood form of the
disease is the classical form and is the most severe. Childhood ALD is
progressive and usually leads to total disability or death. It affects
only boys because the genetic defect is sex-linked (carried on the X
chromosome). Onset usually occurs between ages four and ten and can include many
different symptoms, not all of which appear together. The most common symptoms
are behavioral problems and poor memory. Other symptoms frequently seen are loss
of vision, seizures, poorly articulated speech, difficulty swallowing, deafness,
problems with gait and coordination, fatigue, increased skin
pigmentation, and progressive dementia.
The adult-onset form of the disease, also called
adrenomyeloneuropathy, is milder, progresses slowly, is usually associated with
a normal life span, and usually appears between ages 21-35. Symptoms may include
progressive stiffness, weakness, or paralysis of the lower limbs and loss
of coordination. Brain function deterioration may also been seen. Women who are
carriers of the disease occasionally experience the same symptoms, as well as
others, including ataxia, hypertonia (excessive muscle tone), mild peripheral
neuropathy, and urinary problems. The neonatal form affects both male and
female infants and may produce mental retardation, facial abnormalities,
seizures, retinal degeneration, poor muscle tone, enlarged liver, and adrenal
dysfunction. Neonatal ALD usually progresses
rapidly.
Causes and
Symptoms
The genetic defect in ALD causes a decrease in the ability to degrade
very long chain fatty acids. These build up in the adrenal glands, brain,
plasma, and fibroblasts. The build-up of very long chain fatty acids interferes
with the ability of the adrenal gland to convert cholesterol into steroids and
causes demyelination of nerves in the white matter of the brain. Demyelinated
nerve cells are unable to function properly.
Diagnosis
Diagnosis is made based on observed symptoms, a biochemical test, and
a family history. The biochemical test detects elevated levels of very long
chain fatty acids in samples from amniocentesis, chorionic villi, plasma,
red blood cells, or fibroblasts. A family history may indicate the likelihood of
ALD because the disease is carried on the X-chromosome by the female lineage of
families.
Treatment
Treatment for all forms of ALD consists of treating the symptoms and
supporting the patient with physical therapy, psychological counseling, and
special education in some cases. There is no cure for this disease, and there
are no drugs that can reverse demyelination of nerve and brain cells. Dietary
measures consist of reducing the intake of foods high in fat, which are a source
of very long chain fatty acids. A mixture called Lorenzo's Oil has been shown to
reduce the level of long chain fatty acids if used long term; however, the rate
of myelin loss is unaffected. Experimental bone marrow transplantation
has not been very effective.
Prognosis
Prognosis for childhood and neonatal ALD patients is poor because of
the progressive myelin degeneration. Death usually occurs between one and ten
years after onset of symptoms.
Prevention
Since ALD is a genetic disease, prevention is largely limited to
genetic counseling and fetal monitoring through amniocentesis or
chorionic villus sampling.
Key Terms
Amniocentesis
The collection of amniotic fluid
through a needle inserted through the abdomen. Used to collect fetal cells for
genetic analysis.
Ataxia
Loss of coordination of muscular
movement.
Hypertonia
Having excessive muscular tone.
Myelin
A layer that encloses nerve cells and
some axons and is made largely of lipids and lipoproteins.
Neuropathy
A disease or abnormality of the
peripheral nerves.
For More Information: Please ask your attending physician on your next visit.
| Link Partners | Cell Phone Collection | US Hospitals |
|